Mutant KRAS is well established as a true oncogenic driver – it is sufficient for neoplastic transformation in vitro [15], induces spontaneous tumor formation in genetically-engineered mouse models [16], and its expression is strictly required, even in advanced tumors [17]. This evidence concerns the gene KRAS and neoplasm.